Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Berkshire Hathaway accelerates stock buybacks, operating profit falls
Nov 7 (Reuters) - Berkshire Hathaway on Saturday reported a lower third-quarter operating profit as…
Barcelona gear up for 'tough' game against Atleti
VIDEO SHOWS: BARCELONA HOLD TRAINING SESSION AND BARCELONA COACH HANSI FLICK HOLDS PRESS CONFERENCE AHEAD…
'We have to turn it here': Sharks eager to stop slide in matchup vs. Stars
The San Jose Sharks are foundering as they prepare to visit the Dallas Stars on…
